TrialClinical cancer research : an official journal of the American Association for Cancer Research2026

SARC031: A Phase II Trial of Selumetinib and Sirolimus for Patients with Unresectable or Metastatic Malignant Peripheral Nerve Sheath Tumors (MPNST).

AeRang Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.